APA (7th ed.) Citation

T, T. D., S, K., C, v. N., RJ, H., T, K., SP, v. M., . . . MJM, B. (2022). Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(2), 221. https://doi.org/10.1093/cid/ciab934

Chicago Style (17th ed.) Citation

T, Ten Doesschate, et al. "Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75, no. 2 (2022): 221. https://doi.org/10.1093/cid/ciab934.

MLA (9th ed.) Citation

T, Ten Doesschate, et al. "Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 2, 2022, p. 221, https://doi.org/10.1093/cid/ciab934.